Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $192 | $455 | $471 | $471 |
| - Cash | $95 | $245 | $8 | $1 |
| + Debt | $4 | $0 | $0 | $0 |
| Enterprise Value | $101 | $210 | $463 | $470 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$54 | -$27 | -$7 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$47 | -$27 | -$12 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.22 | -0.76 | -0.47 | -0.28 |
| % Growth | -60.5% | -61.7% | -67.9% | – |
| Operating Cash Flow | -$33 | -$27 | -$5 | -$5 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$33 | -$27 | -$5 | -$5 |